Delivery Order SPE2DB22D1106-SPE2DB24FFMJ9

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,410.22 firm fixed-price contract is for the supply of 140 mg/mL Aimovig autoinjectors, a specialty medication. The contract has an ultimate completion date of September 21, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,070.20 firm fixed-price contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTOR, a medication. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation in the amount of $10,405.29. The order is for the pharmaceutical product Aimovig 70 mg/mL autoinjector. The contract has an ultimate completion date of August 20, 2024 and is a firm fixed price delivery order, with no set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery vehicles to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,504.58, is for the delivery of AIMOVIG 140 MG/ML autoinjectors. The award has a firm fixed price pricing type and an ultimate completion date of March 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Aimovig 140 mg/ml autoinjectors. The contract has a firm fixed price of $8,730.24 and an ultimate completion date of October 16, 2024. This award is under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $6,522.42 and is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price contract type. The contract was not set aside for any specific business type....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Aimovig 140 mg/mL autoinjectors. The contract has a ceiling value of $9,835.91 and runs through April 16, 2024. It is a firm-fixed-price delivery order contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,641.20, is for the delivery of the medication Aimovig 140 mg/ml autoinjector. The contract is a firm fixed-price delivery order, with an ultimate completion date of March 15, 2023. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,587.20, is for the delivery of the medication Aimovig 140 mg/ml autoinjector. The contract has a firm fixed price pricing type and an ultimate completion date of April 3, 2023. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Aimovig 140 mg/ml autoinjectors, a specialty medication. The delivery order is valued at $23,444.86 and has a completion date of September 25, 2024. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFMJ9
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Aimovig (140 mg/mL autoinjector). The contract has a firm fixed price of $20,238.67 and an ultimate completion date of September 12, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order contract is not set aside for any particular business category.

Generated 12/11/24, 9:28 AM